International Isotopes's gross profit for the
three
months ended in Dec. 2024 was $2.32 Mil. International Isotopes's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $8.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of International Isotopes's Gross Profit
For the Drug Manufacturers - Specialty & Generic subindustry, International Isotopes's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Isotopes's Gross Profit Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, International Isotopes's Gross Profit distribution charts can be found below:
* The bar in red indicates where International Isotopes's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.65 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
International Isotopes (OTCPK:INIS) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
International Isotopes had a gross margin of 59.35% for the quarter that ended in Dec. 2024 => Durable competitive advantage
International Isotopes Gross Profit Related Terms
Thank you for viewing the detailed overview of International Isotopes's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, The Theranostics Products Segment, The Medical Devices segment and Fluorine Products. Geographically, it generates the majority of its revenue from Theranostics Products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INIS has been successfully added to your 